SOW
CPRX

State of Wyoming’s Catalyst Pharmaceutical CPRX Stock Holding History

State of Wyoming’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$426K Sell
17,212
-4,347
-20% -$104K 0.05% 431
2025
Q4 		$503K Buy
21,559
+1,144
+6% +$25.5K 0.06% 365
2025
Q3 		$402K Buy
20,415
+2,260
+12% +$46.5K 0.05% 473
2025
Q2 		$394K Buy
18,155
+5,508
+44% +$130K 0.05% 445
2025
Q1 		$307K Sell
12,647
-12,771
-50% -$288K 0.04% 540
2024
Q4 		$530K Buy
25,418
+2,199
+9% +$47.2K 0.07% 235
2024
Q3 		$462K Buy
23,219
+14,993
+182% +$278K 0.07% 222
2024
Q2 		$127K Sell
8,226
-2,269
-22% -$35.3K 0.02% 864
2024
Q1 		$167K Buy
10,495
+1,753
+20% +$26.4K 0.03% 713
2023
Q4 		$147K Sell
8,742
-874
-9% -$11.9K 0.03% 755
2023
Q3 		$112K Sell
9,616
-4,151
-30% -$55.5K 0.02% 786
2023
Q2 		$185K Buy
13,767
+4,249
+45% +$61.1K 0.05% 424
2023
Q1 		$158K Sell
9,518
-10,376
-52% -$171K 0.05% 495
2022
Q4 		$370K Sell
19,894
-7,460
-27% -$115K 0.12% 83
2022
Q3 		$351K Buy
27,354
+3,759
+16% +$44.5K 0.17% 61
2022
Q2 		$165K Sell
23,595
-5,261
-18% -$38.6K 0.1% 208
2022
Q1 		$239K Sell
28,856
-3,877
-12% -$27.4K 0.12% 133
2021
Q4 		$222K Buy
+32,733
New +$215K 0.1% 185

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State of Wyoming's CPRX Position: Q1 2026 in Review

State of Wyoming reduced its Catalyst Pharmaceutical (CPRX) stake by 20% in Q1 2026, selling an estimated $104K and leaving 17,212 shares worth $426K. The position accounts for 0.05% of the portfolio, ranked #431.

State of Wyoming first reported a position in CPRX in Q4 2021 and has held it in 18 quarters since. The position peaked at $530K in Q4 2024. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • State of Wyoming held 17,212 shares of Catalyst Pharmaceutical worth $426K as of Q1 2026.
  • State of Wyoming sold 4,347 Catalyst Pharmaceutical shares in Q1 2026, an estimated $104K.
  • Catalyst Pharmaceutical made up 0.05% of State of Wyoming's portfolio in Q1 2026, its #431 holding.
  • State of Wyoming first reported a position in Catalyst Pharmaceutical in Q4 2021 and has held it in 18 quarters since.
  • State of Wyoming's Catalyst Pharmaceutical position peaked at $530K in Q4 2024.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.